T2 biosystems — etc
T2 biosystems — etc

T2 Biosystems is an American company, established in 2006 developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths – and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics.

Description

Device Feature :

T2Dx Instrument:

  • LoD as low as 1 CFU/ml
  • Easy to operate.
  • Minimal hands-on time.
  • Results in 3 to 5 hours.

T2 Resistance Panel* :

Gram-negative species.

  • KPC
  • OXA-48
  • NDM/VIM/IMP
  • CTX-M 15/14
  • AmpC(CMY/DHA)

Gram-positive species.

  • van A/B
  • mecA/C

T2Bacteria Panel:

95.8% Sensitivity**

  • Enterococcus faecium.
  • Staphylococcus aureus.
  • Klebsiella pneumoniae.
  • Acinetobacter baumannii.
  • Pseudomonas aeruginosa.
  • Escherichia coli.

98.2% Specificity.

 

T2Bacteria Panel:

91.1% Sensitivity

  • Candida albicans.
  • Candida tropicalis.
  • Candida krusei.
  • Candida glabrata.
  • Candida parapsilosis.

99.4% Specificity.